Armistice Capital’s GeoVax Labs GOVX Stock Holding History

Armistice Capital’s Portfolio GOVX Stock Details GOVX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$372K	Buy	+269,253	New	+$645K	0.01%	182
2025 Q4	–	Sell	-21,356	Closed	-$253K	–	422
2025 Q3	$253K	Buy	+21,356	New	+$374K	﹤0.01%	281
2025 Q2	–	Sell	-26,515	Closed	-$703K	–	228
2025 Q1	$703K	Buy	+26,515	New	+$1.17M	0.01%	175
2024 Q3	–	Sell	-3,200	Closed	-$255K	–	288
2024 Q2	$255K	Sell	3,200 -3,920	-55%	-$172K	﹤0.01%	197
2024 Q1	$356K	Buy	7,120 +2,783	+64%	+$220K	﹤0.01%	231
2023 Q4	$587K	Buy	+4,337	New	+$759K	0.01%	194
2022 Q3	–	Sell	-3,623	Closed	-$1.13K	–	218
2022 Q2	$1.13K	Buy	3,623 +2,463	+212%	+$1.09M	0.02%	125
2022 Q1	$500K	Buy	+1,160	New	+$922K	0.01%	119
2020 Q4	–	Sell	-135	Closed	-$161K	–	115
2020 Q3	$161K	Buy	+135	New	+$150K	0.01%	101

Other funds holding GOVX

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return

VFT

Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

SBI Securities Tokyo, Japan $4.4B AUM 74.26% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Armistice Capital's GOVX Position: Q1 2026 in Review

Armistice Capital opened a new position in GeoVax Labs (GOVX) in Q1 2026: 269,253 shares worth $372K. The stake represents 0.01% of the portfolio and ranks #182 among its holdings. This is a return to the name: Armistice Capital previously reported a position in GOVX as recently as Q3 2025.

Armistice Capital first reported a position in GOVX in Q3 2020 and has held it in 9 quarters since. The position peaked at $703K in Q1 2025. 16 funds tracked by Wall St. Rank hold GOVX as of Q1 2026.

Armistice Capital held 269,253 shares of GeoVax Labs worth $372K as of Q1 2026.
GeoVax Labs was a new Armistice Capital position in Q1 2026.
GeoVax Labs made up 0.01% of Armistice Capital's portfolio in Q1 2026, its #182 holding.
Armistice Capital first reported a position in GeoVax Labs in Q3 2020 and has held it in 9 quarters since.
Armistice Capital's GeoVax Labs position peaked at $703K in Q1 2025.
16 funds tracked by Wall St. Rank held GeoVax Labs as of Q1 2026.

Based on Armistice Capital's 13F filing for Q1 2026, filed 15 May 2026.